Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI) -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (498)	1/4/2004 2:59:37 PM
From: SemiBull	Read Replies (1) \| Respond to of 668

Curis files $40 mln shelf for stock, warrants Tuesday December 23, 5:32 pm ET WASHINGTON, Dec 23 (Reuters) - Curis Inc. (NasdaqNM:CRIS - News), a Cambridge, Massachusetts-based drug development company, filed to sell from time to time up to $40 million in common and preferred stock and warrants. The company plans to use the net proceeds to develop and market its products, finance its expansion, cut debt, acquire businesses and products, and other capital spending, according to the shelf registration filed with the Securities and Exchange Commission (News - Websites) .